#ASCO22: Mingling face-to-face stole the spotlight in reunion with '50,000 of your closest friends'

Kyle LaHucik

Senior Reporter

CHICAGO — This weekend, tens of thousands of physicians, clinical trial investigators, academics, R&D scientists and biopharma leaders descended upon Chicago for the first in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#ASCO22: Mingling face-to-face stole the spotlight in reunion with '50,000 of your closest friends'

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

#AS­CO22: Min­gling face-to-face stole the spot­light in re­union with '50,000 of your clos­est friend­s'

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

#ASCO22: Mingling face-to-face stole the spotlight in reunion with '50,000 of your closest friends'